Cancer nanomedicine: progress, challenges and opportunities

Jinjun Shi, Philip W. Kantoff, Richard Wooster

Feb 23, 2026·06:40·

00:00

06:40

Cancer nanomedicineEnhanced Permeability and Retention (EPR) effectNano–bio interactionsTumor heterogeneityClinical translation challengesEnhanced Permeability and Retention (EPR) Effect

About This Paper

DOI: 10.1038/nrc.2016.108

Turn any paper into a podcast

ResearchPod turns research papers into podcasts you can actually follow.

Download on the App Store